No results for ‘’
Lasa Supergenerics Ltd
₹7.51
(3.84%)
Thu, 25 Jun 2026, 08:27 am
Health Technology
Pharmaceuticals: Major
24.5KLasa Supergenerics Enterprise Value (EV)
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 16.69 | 0 | 31.83 | 10.70 | 0 | 0 | 0 | 0 |
| Price to book ratio | 0 | 1.77 | 0.50 | 0.82 | 1.53 | 1.32 | 0.78 | 1.14 | 1.01 |
| Price to sales ratio | 0 | 0.85 | 0.31 | 0.69 | 1.21 | 1.52 | 0.71 | 1.05 | 0.59 |
| Price to cash flow ratio | 0 | 6.36 | 1.61 | 20.09 | 6.18 | 22.55 | 0 | 1490 | 0 |
| Enterprise value | 0 | 305Cr | 135Cr | 158Cr | 259Cr | 212Cr | 112Cr | 131Cr | 85.76Cr |
| Enterprise value to EBITDA ratio | 0 | 7.38 | 11.86 | 4.80 | 5.44 | 12.59 | 0 | 60.32 | 13.69 |
| Debt to equity ratio | 1.51 | 0.86 | 0.80 | 0.34 | 0.12 | 0.13 | 0.18 | 0.23 | 0.03 |
| Return on equity % | 0 | 12.80 | -10.81 | 2.94 | 15.17 | -3.37 | -28.94 | -20.22 | -16.36 |
Lasa Supergenerics Ltd Enterprise Value
The Lasa Supergenerics Ltd Enterprise Value is a key financial metric used by investors to evaluate Lasa Supergenerics Ltd's valuation, profitability, and overall financial performance. Tracking the Lasa Supergenerics Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Lasa Supergenerics Ltd (NSE: LASA, BSE: 540702) is currently trading at ₹7.51, with a market capitalization of ₹37.83Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Lasa Supergenerics Ltd Enterprise Value is essential for fundamental analysis.
Lasa Supergenerics Ltd Enterprise Value Current Value
The current Lasa Supergenerics Ltd Enterprise Value stands at 85.76Cr.
The Lasa Supergenerics Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Lasa Supergenerics Ltd Enterprise Value Historical Trend
The Lasa Supergenerics Ltd Enterprise Value has shown the following historical trend:
- 2024: 85.76Cr
- 2023: 131Cr
- 2022: 112Cr
- 2021: 212Cr
- 2020: 259Cr
The decline in Lasa Supergenerics Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Lasa Supergenerics Ltd Enterprise Value Indicates for Investors
The Lasa Supergenerics Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Lasa Supergenerics Ltd.
Lasa Supergenerics Ltd Enterprise Value Analysis Summary
The Lasa Supergenerics Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Lasa Supergenerics Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Lasa Supergenerics Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.